| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.545 | 20.007 | 27.750 | 35.249 | 31.053 | 30.116 | 40.691 | 39.228 | 33.776 | 33.250 |
| Total Income - EUR | 15.545 | 20.007 | 27.750 | 35.249 | 31.053 | 30.116 | 40.691 | 39.228 | 33.776 | 33.250 |
| Total Expenses - EUR | 3.568 | 2.074 | 1.980 | 1.478 | 1.341 | 1.602 | 1.526 | 313 | 10.727 | 25.665 |
| Gross Profit/Loss - EUR | 11.977 | 17.934 | 25.770 | 33.771 | 29.713 | 28.514 | 39.165 | 38.915 | 23.049 | 7.585 |
| Net Profit/Loss - EUR | 11.510 | 17.334 | 24.938 | 32.713 | 28.781 | 27.677 | 37.987 | 37.779 | 22.723 | 6.621 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Mediserv Neagu & Vlase Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 540 | 406 | 274 | 145 | 22 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9.729 | 27.827 | 51.172 | 33.568 | 30.057 | 29.321 | 39.943 | 41.374 | 23.650 | 10.872 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.043 | 26 | 139 | 1.536 | 1.525 | 1.548 | 1.974 | 30.368 | 2.338 | 1.999 |
| Cash | 8.686 | 27.801 | 51.032 | 32.032 | 28.532 | 27.773 | 37.969 | 11.006 | 21.312 | 8.873 |
| Shareholders Funds | 7.378 | 24.636 | 49.157 | 32.764 | 28.831 | 27.741 | 38.049 | 37.842 | 22.786 | 6.684 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 56 | 55 | 55 | 55 | 54 |
| Debts | 2.891 | 3.597 | 2.289 | 949 | 1.247 | 1.580 | 1.894 | 3.532 | 864 | 4.189 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mediserv Neagu & Vlase Srl